Compare PDEX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDEX | FBIO |
|---|---|---|
| Founded | 1978 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 113.9M |
| IPO Year | N/A | N/A |
| Metric | PDEX | FBIO |
|---|---|---|
| Price | $40.42 | $3.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $56.00 | $16.50 |
| AVG Volume (30 Days) | 27.8K | ★ 1.2M |
| Earning Date | 02-02-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.94 | N/A |
| EPS | ★ 3.31 | N/A |
| Revenue | ★ $70,231,000.00 | $62,303,000.00 |
| Revenue This Year | $7.22 | $29.71 |
| Revenue Next Year | N/A | $49.34 |
| P/E Ratio | $12.32 | ★ N/A |
| Revenue Growth | ★ 23.65 | N/A |
| 52 Week Low | $23.47 | $1.33 |
| 52 Week High | $70.26 | $4.53 |
| Indicator | PDEX | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 47.17 |
| Support Level | $39.61 | $3.33 |
| Resistance Level | $43.39 | $3.79 |
| Average True Range (ATR) | 2.02 | 0.33 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 51.69 | 18.36 |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.